News
AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback